RocketTickers

RedHill Biopharma Announces Positive Recommendation from Indepen

Long
NASDAQ:RDHL   Redhill Biopharma Ltd.
RDHL: RedHill Biopharma Ltd.
2020-08-27 07:00:10
RedHill Biopharma Announces Positive Recommendation from Independent Committee to Continue U.S. Phase 2 COVID-19 Study, and Approval of COVID-19 Phase 2/3 Study in Italy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.